The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.50
Bid: 165.00
Ask: 190.00
Change: 0.00 (0.00%)
Spread: 25.00 (15.152%)
Open: 177.50
High: 177.50
Low: 177.50
Prev. Close: 177.50
ATY Live PriceLast checked at -
Athelney is an Investment Trust

To provide shareholders with prospects of long term capital growth by investing in companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

2 Feb 2021 09:55

RNS Number : 7095N
Athelney Trust PLC
02 February 2021
 

Athelney Trust PLC

 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 256.2p at 31 January 2021.

Fund Manager's comment for January 2021

The renewed optimism at the beginning of the financial year was tempered by the announcement by the Prime Minister of a new nationwide lockdown that would once again have a negative impact on the economy which had been struggling to gather momentum in recent months. The impact of previous COVID lockdowns on the economy was clearly evident in recent economic data where December retail sales were only marginally up by 0.3% month-on-month after declining by 4.1% in November and November GDP fell 2.6% month-on-month, primarily due to a fall in service output of 3.4% and industrial output of 0.1%.

The MSCI declined by 1.1% during the month largely due to a weaker US market where the S&P500 also declined by 1.1% on the back of a loss of momentum toward the end of the quarter as economists forecast weaker trading conditions in the first quarter of this year. The FOMC left policy unchanged at its January meeting, keeping the federal funds rate unchanged at near zero while continuing to purchase Treasury securities and mortgage-backed securities. The other major markets performed poorly with the CAC down 2.9% and the DAX declining by 2.1%.

In the UK, markets reflected the sombre outlook for the economy with the FTSE 250 Index closing down by 1.3% over the month. The small cap stocks again performed better than large cap stocks with the Small Cap Index increasing by 0.2% as compared to the FTSE 100 Index which declined by 0.8%. The AIM All Share Index increased by 0.3% while the Fledgling Index was the best performer, increasing by 1.7% during the month.

In spite of a continuing sector rotation between growth and value, our growth-oriented portfolio increased by 0.6%. After allowing for expenses, the NAV increased by 0.4% over the month, an excellent result given current circumstances and market conditions. As we await company announcements on current trading, we have decided to remain fully invested, making no changes to our existing positions during January with cash comprising 3.5% of the portfolio at month end.

 

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "Portfolio Details".

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (licence no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has over AU$1500m under its management including four listed investment companies, three listed in Australia and one in the UK:

· Flagship Investments (ASX code:FSI)

AUD50m https://flagshipinvestments.com.au

· Barrack St Investments (ASX code: BST)

AUD25m www.barrackst.com

· Global Masters Fund Limited (ASX code: GFL)

AUD25m www.globalmastersfund.com.au

· Athelney Trust plc (LSE code: ATY)

GBP5m www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

 The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is one of only "22 investment companies that have increased their dividend every year between 10 and 20 years - the next generation of dividend heroes" (as at 20/03/2018). See link

www.theaic.co.uk/aic/news/press-releases/next-generation-of-dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVGCGDDUUGDGBD
Date   Source Headline
4th Apr 20249:21 amRNSNet Asset Value(s)
22nd Mar 20248:15 amRNSAGM Statement
5th Mar 20242:04 pmRNSNet Asset Value(s)
13th Feb 202411:58 amRNSDividend Declaration
5th Feb 202410:17 amRNSNet Asset Value(s)
3rd Jan 202411:13 amRNSNet Asset Value(s)
5th Dec 20232:45 pmRNSNet Asset Value(s)
6th Nov 20237:00 amRNSNet Asset Value(s)
20th Oct 20237:29 amRNSAuditor appointment
10th Oct 202310:54 amRNSChange of Adviser
4th Oct 20232:58 pmRNSNet Asset Value(s)
4th Sep 202311:17 amRNSNet Asset Value(s)
2nd Aug 20239:06 amRNSNet Asset Value(s)
25th Jul 202311:37 amRNSHalf-year Report
4th Jul 20238:50 amRNSNet Asset Value(s)
5th Jun 20237:28 amRNSNet Asset Value(s)
3rd May 202310:14 amRNSNet Asset Value(s)
4th Apr 202312:05 pmRNSNet Asset Value(s)
17th Mar 20231:15 pmRNSResult of AGM
2nd Mar 202312:39 pmRNSNet Asset Value(s)
13th Feb 20236:02 pmRNSAnnual Financial Report
2nd Feb 20237:00 amRNSNet Asset Value(s)
9th Jan 202310:11 amRNSNet Asset Value(s)
5th Dec 20227:51 amRNSNet Asset Value(s)
2nd Nov 20227:50 amRNSNet Asset Value(s)
4th Oct 20229:02 amRNSNet Asset Value(s)
5th Sep 20227:09 amRNSNet Asset Value(s)
2nd Aug 202211:57 amRNSNet Asset Value(s)
26th Jul 202212:44 pmRNSHalf-year Report
4th Jul 20229:13 amRNSNet Asset Value(s)
6th Jun 20229:36 amRNSNet Asset Value(s)
4th May 20227:56 amRNSNet Asset Value(s)
5th Apr 20223:10 pmRNSAGM Statement
4th Apr 20229:55 amRNSNet Asset Value(s)
2nd Mar 202211:33 amRNSNet Asset Value(s)
23rd Feb 20221:13 pmRNSAnnual Financial Report
2nd Feb 20229:05 amRNSNet Asset Value(s)
12th Jan 20225:03 pmRNSHolding(s) in Company
12th Jan 20225:00 pmRNSHolding(s) in Company
12th Jan 20225:00 pmRNSHolding(s) in Company
5th Jan 20228:14 amRNSNet Asset Value(s)
3rd Dec 202112:00 pmRNSNet Asset Value(s)
2nd Nov 20218:12 amRNSNet Asset Value(s)
4th Oct 202111:40 amRNSNet Asset Value(s)
2nd Sep 202111:44 amRNSNet Asset Value(s)
3rd Aug 20211:18 pmRNSNet Asset Value(s)
27th Jul 202111:20 amRNSHalf-year Report
2nd Jul 20218:32 amRNSNet Asset Value(s)
3rd Jun 20218:19 amRNSNet Asset Value(s)
5th May 20219:19 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.